Literature DB >> 21128711

Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005-2009.

Iara Trocoli Drakensjö1, Erja Chryssanthou.   

Abstract

Dermatophytic infections are common worldwide but the distribution of dermatophyte species varies among geographical areas and changes over time. The aim of this study was to determine the epidemiologic profile of dermatophytosis in Stockholm, Sweden. Laboratory records comprising direct microscopy and culture results of 37,503 specimens from skin, hair and nail scrapings collected from January 2005 through December 2009 were retrospectively analyzed in the mycology laboratory at Karolinska University Hospital. Onychomycosis had, over time, the highest overall prevalence of 14.1%, followed by tinea pedis (4.4%). Trichophyton rubrum was the predominant pathogen isolated from these cases (83.2%), followed by T. mentagrophytes (7.4 %). In contrast, T. violaceum and T. soudanense accounted for 81.6% of the isolates from patients with tinea capitis.

Entities:  

Mesh:

Year:  2010        PMID: 21128711     DOI: 10.3109/13693786.2010.540045

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  19 in total

1.  A 10-Year Study of Dermatophytoses in Isfahan, Iran.

Authors:  Mostafa Chadeganipour; Rasoul Mohammadi; Shahla Shadzi
Journal:  J Clin Lab Anal       Date:  2015-04-23       Impact factor: 2.352

2.  Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.

Authors:  Emilia Ghelardi; Francesco Celandroni; Sokhna Aissatou Gueye; Sara Salvetti; Sonia Senesi; Anna Bulgheroni; Federico Mailland
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

3.  Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis.

Authors:  Hiroyasu Koga; Yasuko Nanjoh; Hideo Kaneda; Hideyo Yamaguchi; Ryoji Tsuboi
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

4.  Epidemiology of Dermatophytes in Belgium: A 5 Years' Survey.

Authors:  Sacheli Rosalie; Cuypers Lize; Seidel Laurence; Darfouf Rajae; Adjetey Caroline; Lagrou Katrien; Hayette Marie-Pierre
Journal:  Mycopathologia       Date:  2021-04-26       Impact factor: 2.574

5.  Correlation of clinical characteristics, by calculation of SCIO index, with the laboratory diagnosis of onychomycosis.

Authors:  Eleonora Dubljanin; Aleksandar Dzamic; Isidora Vujcic; Stefan Mijatovic; Teodora Crvenkov; Sandra Sipetic Grujicic; Ivana Colovic Calovski
Journal:  Braz J Microbiol       Date:  2022-01-08       Impact factor: 2.476

6.  Epidemiology of Tinea Capitis in Children in Beijing and Adjacent Regions, China: A 15-Year Retrospective Study.

Authors:  Yuan Yuan Xiao; Ya Bin Zhou; Jin Jing Chao; Lin Ma
Journal:  Mycopathologia       Date:  2022-08-18       Impact factor: 3.785

7.  Antifungal activity and potential mechanism of magnoflorine against Trichophyton rubrum.

Authors:  Nanxuan Luo; Liang Jin; Changqing Yang; Yurong Zhu; Xiaoli Ye; Xuegang Li; Baoshun Zhang
Journal:  J Antibiot (Tokyo)       Date:  2020-10-20       Impact factor: 2.649

Review 8.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

9.  Epidemiology of Superficial Fungal Infections in Guangdong, Southern China: A Retrospective Study from 2004 to 2014.

Authors:  Wenying Cai; Changming Lu; Xiqing Li; Junmin Zhang; Ping Zhan; Liyan Xi; Jiufeng Sun; Xinbing Yu
Journal:  Mycopathologia       Date:  2016-02-16       Impact factor: 2.574

10.  Superficial Fungal Infections in a French Teaching Hospital in Grenoble Area: Retrospective Study on 5470 Samples from 2001 to 2011.

Authors:  O Faure-Cognet; H Fricker-Hidalgo; H Pelloux; M T Leccia
Journal:  Mycopathologia       Date:  2015-10-09       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.